Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 9, 2021

Chorioamnionitis after premature rupture of membranes in nulliparas undergoing labor induction: prostaglandin E2 vs. oxytocin

  • Moti Gulersen ORCID logo EMAIL logo , Cristina Zottola , Xueying Li , David Krantz , Mariella DiSturco and Eran Bornstein ORCID logo

Abstract

Objectives

To assess the risk of chorioamnionitis in nulliparous, term, singleton, vertex (NTSV) pregnancies with premature rupture of membranes (PROM) and an unfavorable cervix undergoing labor induction with either prostaglandin E2 (PGE2) or oxytocin only.

Methods

Retrospective cohort of NTSV pregnancies presenting with PROM who underwent labor induction with either PGE2 (n=94) or oxytocin (n=181) between October 2015 and March 2019. The primary outcome of chorioamnionitis was compared between the two groups. Statistical analysis included Chi-squared and Wilcoxon rank-sum tests, as well as logistic regression. For time to delivery, a Cox proportional hazard regression was used to determine the hazard ratio (HR) and adjusted HR (aHR).

Results

Baseline characteristics were similar between the two groups. Cervical ripening with PGE2 was associated with an increased rate of chorioamnionitis (18.1 vs. 6.1%; aOR 4.14, p=0.001), increased neonatal intensive care unit admissions (20.2 vs. 9.9%; aOR 2.4, p=0.02), longer time interval from PROM to delivery (24.4 vs. 17.9 h; aHR 0.56, p=<0.0001), and lower incidence of meconium (7.4 vs. 14.4%; aOR 0.26, p=0.01), compared to the oxytocin group.

Conclusions

Based on our data, the use of oxytocin appears both superior and safer compared to PGE2 in NTSV pregnancies with PROM undergoing labor induction.


Corresponding author: Moti Gulersen, MD, MSc, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, North Shore University Hospital – Zucker School of Medicine at Hofstra/Northwell, 300 Community Drive, Manhasset, NY 11030, USA; and Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Lenox Hill Hospital – Zucker School of Medicine at Hofstra/Northwell, New York, NY, USA, Phone: +516 562 2892, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: The local Institutional Review Board approval was obtained.

References

1. American College of Obstetricians and Gynecologists. Prelabor rupture of membranes. ACOG practice bulletin number 217. Washington, DC: American College of Obstetricians and Gynecologists; 2020.Search in Google Scholar

2. Martin, JA, Hamilton, BE, Sutton, PD, Ventura, SJ, Menacker, F, Munson, ML. Births: final data for 2003. Natl Vital Stat Rep 2005;54:1–116.Search in Google Scholar

3. Middleton, P, Shepherd, E, Flenady, V, McBain, RD, Crowther, CA. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database Syst Rev 2017;1:CD005302. https://doi.org/10.1002/14651858.CD005302.pub3.Search in Google Scholar

4. American College of Obstetricians and Gynecologists. Induction of Labor. ACOG practice bulletin number 107. Washington, DC: American College of Obstetricians and Gynecologists; 2009.Search in Google Scholar

5. Thomas, J, Fairclough, A, Kavanagh, J, Kelly, AJ. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev 2014;2014:CD003101. https://doi.org/10.1002/14651858.CD003101.pub3.Search in Google Scholar

6. Ashwal, E, Hiersch, L, Melamed, N, Manor, Y, Wiznitzer, A, Hod, M, et al.. Pre-induction cervical ripening: comparing between two vaginal preparations of dinoprostone in women with an unfavorable cervix. J Matern Fetal Neonatal Med 2014;27:1874–9. https://doi.org/10.3109/14767058.2014.883375.Search in Google Scholar

7. Gungorduk, K, Asiciogly, O, Besimoglu, B, Gungorduk, OC, Yildirm, G, Ark, C, et al.. Labor induction in term premature rupture of membranes: comparison between oxytocin and dinoprostone followed 6 hours later by oxytocin. Am J Obstet Gynecol 2012;206:60.e1–8. https://doi.org/10.1016/j.ajog.2011.07.035.Search in Google Scholar

8. Triglia, MT, Palamara, F, Lojacono, A, Prefumo, F, Frusca, T. A randomized controlled trial of 24-hour vaginal dinoprostone pessary compared to gel for induction of labor in term pregnancies with a Bishop score < or = 4. Acta Obstet Gynecol Scand 2010;89:651–7. https://doi.org/10.3109/00016340903575998.Search in Google Scholar

9. Ornat, L, Alonso-Ventura, V, Bueno-Notivol, J, Chedraui, P, Perez-Lopez, FR. Health Outcomes and Systematic Analyses (HOUSSAY) Research Group. Misoprostol combined with cervical single or double balloon catheters versus misoprostol alone for labor induction of singleton pregnancies: a meta-analysis of randomized trials. J Matern Fetal Neonatal Med 2020;33:3453–68. https://doi.org/10.1080/14767058.2019.1574741.Search in Google Scholar

10. Solt, I, Frank Wolf, M, Ben-Haroush, S, Kaminskyi, S, Ophir, E, Bornstein, J. Foley catheter versus cervical double balloon for labor induction: a prospective randomized study. J Matern Fetal Neonatal Med 2019 [Epub ahead of print].10.1080/14767058.2019.1623776Search in Google Scholar

11. Hannah, ME, Ohlsson, A, Farine, D, Hewson, SA, Hodnett, ED, Myhr, TL, et al.. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group. N Engl J Med 1996;334:1005–10. https://doi.org/10.1056/nejm199604183341601.Search in Google Scholar

12. Kunt, C, Kanat-Pektas, M, Gungor, AN, Kurt, RK, Ozat, M, Gulerman, C, et al.. Randomized trial of vaginal prostaglandin E2 versus oxytocin for labor induction in term premature rupture of membranes. Taiwan J Obstet Gynecol 2010;49:57–61. https://doi.org/10.1016/s1028-4559(10)60010-1.Search in Google Scholar

13. Kulhan, NG, Kulhan, M. Labor induction in term nulliparous women with premature rupture of membranes: oxytocin versus dinoprostone. Arch Med Sci 2019;15:896–901. https://doi.org/10.5114/aoms.2018.76115.Search in Google Scholar PubMed PubMed Central

14. American College of Obstetricians and Gynecologists. Intrapartum Management of Intraamniotic Infection. ACOG committee opinion number 712. Washington, DC: American College of Obstetricians and Gynecologists; 2017.Search in Google Scholar

15. Kim, CJ, Romero, R, Chaemsaithong, P, Chaiyasit, N, Yoon, BH, Kim, YM. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol 2015;213:S29–52. https://doi.org/10.1016/j.ajog.2015.08.040.Search in Google Scholar

16. Chung, T, Rogers, MS, Gordon, H, Chang, A. Prelabor rupture of the membranes at term and unfavourable cervix; a randomized placebo-controlled trial on early intervention with intravaginal prostaglandin E2 gel. Aust N Z J Obstet Gynaecol 1992;32:25–7. https://doi.org/10.1111/j.1479-828x.1992.tb01892.x.Search in Google Scholar

17. Mahmood, TA, Dick, MJ, Smith, NC, Templeton, AA. Role of prostaglandin in the management of prelabour rupture of the membranes at term. Br J Obstet Gynaecol 1992;99:112–7. https://doi.org/10.1111/j.1471-0528.1992.tb14466.x.Search in Google Scholar

18. Mahmood, TA, Dick, MJ. A randomized trial of management of pre-labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstet Gynecol 1995;85:71–4. https://doi.org/10.1016/0029-7844(94)00316-6.Search in Google Scholar

19. Shah, K, Doshi, H. Premature rupture of membrane at term: early induction versus expectant management. J Obstet Gynaecol India 2012;62:172–5. https://doi.org/10.1007/s13224-012-0172-6.Search in Google Scholar

20. Wing, DA, Rahall, A, Jones, MM, Goodwin, TM, Paul, RH. Misoprostol: an effective agent for cervical ripening and labor induction. Am J Obstet Gynecol 1995;172:1811–6. https://doi.org/10.1016/0002-9378(95)91416-1.Search in Google Scholar

21. Hofmeyr, GJ, Gulmezoglu, AM, Pileggi, C. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev 2010;2010:CD000941. https://doi.org/10.1002/14651858.CD000941.pub2.Search in Google Scholar PubMed PubMed Central

Received: 2021-02-19
Accepted: 2021-05-27
Published Online: 2021-06-09
Published in Print: 2021-11-25

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 26.5.2024 from https://www.degruyter.com/document/doi/10.1515/jpm-2021-0094/html
Scroll to top button